Literature regarding the differences in gut microbiota between exclusively breastfed (EBF) and non-EBF infants is meager with large variation in methods and results. We performed a metaanalysis of seven studies (a total of 1825 stool samples from 684 infants) to investigate effects of EBF compared to non-EBF on infant gut microbiota across different populations. In the first 6 months of life, overall bacterial diversity, gut microbiota age, relative abundances of Bacteroidetes and Firmicutes and microbial-predicted pathways related to carbohydrate metabolism were consistently increased; while relative abundances of pathways related to lipid, vitamin metabolism and detoxification were decreased in non-EBF vs. EBF infants. The perturbation in microbial-predicted pathways associated with non-EBF was larger in infants 3! ! delivered by C-section than delivered vaginally. Longer duration of EBF mitigated diarrheaassociated gut microbiota dysbiosis and the effects of EBF persisted after 6 months of age. These consistent findings across vastly different populations suggest that one of the mechanisms of short and long-term benefits of EBF may be alteration in gut microbes.
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! decreases long-term risk of diabetes and obesity as compared to non-EBF or formula-fed infants [25] [26] [27] . We hypothesize that the numerous benefits of EBF may be in part due to its effects on the infant gut microbiota. Several recent studies have identified varying differences in gut microbial composition or diversity between EBF and non-EBF infants 5, [28] [29] [30] or gradients in the gut microbiota composition or diversity across EBF, non-EBF and non-breastfed (non-BF) infants 5, 14, 29, 31, 32 . However, some other studies have found no significant differences in gut microbial communities between EBF and non-EBF infants 3, 33 . In addition, mode of delivery has been variably reported to have no effect 34 or a significant effect 30 or a potential interaction effect with breastfeeding 31 on the infant gut microbiota. The wide variation in reported results together with heterogeneity in feeding category definitions, study designs, study populations, and especially in data processing and analysis methods make these findings difficult to synthesize and interpret.
In this study, we applied appropriate and robust statistical methods to analyze gut microbiome data and performed meta-analyses pooling estimates from seven microbiome studies (a total of 1825 stool samples from 684 infants) to investigate the effects of EBF compared to non-EBF on infant gut microbiota in the first 6 months of life across different populations. In addition, we evaluated effect modification by infants' mode of delivery. We aimed to synthesize existing data and to examine consistency or inconsistency in findings across studies and populations. Where data were available, we also examined persisting effects of EBF occurring in the first 6 months on the gut microbiota of infants after 6 months of life as well as interaction effects between diarrhea and EBF on the infant gut microbiota.
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Results
Gut microbial diversity is increased in non-EBF vs. EBF infants ≤ 6 months of age
In infants ≤ 6 months of age, across the seven included studies, non-EBF consistently associated with increased gut microbial alpha diversity (standardized Shannon index) compared to EBF adjusting for infant age at sample collection (pooled standardized diversity difference (DD)= 0.34 standard deviation (sd), 95% confidence interval (95% CI In sensitivity meta-analyses excluding estimates from either the USA (NC) study 29 (which contained a small number of infants ≤ 6 months old), or the Haiti study 3 (which included samples from HIV-uninfected infants born to HIV-infected and HIV-uninfected mothers) or the Vitamin D Antenatal Asthma Reduction Trial (VDAART) study 18 in the USA (CA-MA-MO) (which contained samples from infants at high risk of asthma and allergies, half of whom were randomized to high-dose antenatal vitamin D supplementation), the results remained similar (Supplementary figure 1).
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! In a subset of four studies (Canada 31 , Haiti 3 , USA (CA-FL) 5 , and USA (CA-MA-MO) 18 ) with available data on mode of delivery, the increase in microbial diversity associated with non-EBF was similar in the meta-analysis stratified on vaginally-delivered infants and on cesareandelivered infants (Supplementary figure 2).
Gut microbiota age is increased in non-EBF vs. EBF infants ≤ 6 months of age
A Random Forest (RF) model was used to predict the infant age in each included study based on relative abundances of the shared gut bacterial genera of the seven included study (Supplementary table 1) . The model explained 95% of the variance related to chronologic age in the training set and 65% of the variance related to chronologic age in the test set of Bangladesh data (Supplementary figure 3) . The predicted infant age in each included study based on relative abundances of the shared gut bacterial genera using this Random Forest model was regarded as gut microbiota age.
In infants ≤ 6 months of age, a consistent (6/7 studies) increase of gut microbiota age was observed in non-EBF as compared to EBF infants after adjusting for infant age at sample collection (pooled standardized microbiota age difference (MD)= 0.33 sd, 95%CI= [0.09; 0.58], pooled p-value=!0.0074) (Figure 2a, Figure 2b ). In sensitivity meta-analyses excluding either of the three studies mentioned above 3, 18, 29 , the association remained unchanged (Supplementary figure 4) . In the subset of four studies with available data on mode of delivery 3, 5, 18, 31 , metaanalysis stratified on vaginally-delivered infants and on cesarean-delivered infants showed similar overall increase in microbiota age in non-EBF vs. EBF infants (Supplementary figure 5).
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The trend of increasing gut microbiota age in infants with less breastfeeding after adjusting for age of infants at sample collection was also observed in a subset of five studies containing a non- (Figure 2c ).
Gut microbial composition is altered in non-EBF vs. EBF infants ≤ 6 months of age
Across the seven included studies, there was a large heterogeneity in the difference (log(odds ratio)) of gut bacterial taxa relative abundances between non-EBF vs. EBF infants after adjusting for age of infants at sample collection. Notably, a decrease in relative abundance of In sensitivity meta-analyses excluding either of the three studies mentioned above 3, 18, 29 , results remained similar (Supplementary table 4, Supplementary table 5, Supplementary table 6 ).
In the subset of four studies with available data on mode of delivery 3, 5, 18, 31 , the results of metaanalysis stratified on vaginally-delivered infants were similar to those of meta-analysis stratified on cesarean-delivered infants from the phylum to family level. Phylum Proteobacteria 
Duration of EBF in the first 6 months alters infant gut microbiota after 6 months of age
Using data from the Bangladesh study only, which included 996 stool samples collected monthly from birth to 2 years of life in 50 subjects, we found that shorter duration of EBF (less than 2 months vs. more than 2 months from birth) was associated with a larger increase in gut microbiota age. This association was significant from 6 months to 15 months of age (microbiota age difference (MD)=!1.64 months, 95%CI=(0.23, 3.05), p-value=0.0233) (Figure 5a ). Breastfeeding mitigates diarrhea-associated gut microbiota dysbiosis in infants from 6 months to 2 years of age Again, using data from the Bangladesh study, we found that, after adjusting for age of infants at sample collection, diarrhea at the time of sample collection (vs. no diarrhea) was associated with reduced gut microbiota age in infants who received less than 2 months of EBF (MD=!-1.17
months, 95% CI= (-2.11;-0.23), p=!0.0146) (Figure 5c ). Diarrhea in infants who received less than 2 months of EBF was also associated with reduced gut microbial diversity as showed by
Shannon index (diversity difference =-0.58, 95%CI=(-0.83,-0.34), p<0.0001) (Figure 5d ) and the three other common alpha diversity indices (Supplementary figure 14) . In contrast, no diarrheaassociated differences in gut microbiota age or microbial diversity was observed in infants who received more than two months of EBF (all p-values for heterogeneity tests <0.05).
Diarrhea at the time of sample collection was also associated with major perturbation in the gut bacterial composition of infants who received less than 2 months of EBF with a significant 
Discussion
Our study analyzed data from seven microbiome studies and performed meta-analysis pooling estimates across studies with a total of 1825 stool samples of 684 infants from five countries. We found remarkably consistent differences between non-EBF vs. EBF infants in gut microbial diversity, microbiota age, microbial composition and microbial predicted functional pathways.
The infants' mode of delivery modified these effects. We also found notable interaction effects between breastfeeding and diarrhea on infant gut microbiota. With large datasets combined from different populations, our results are more robust and generalizable than from a single study.
Prior studies have reported increased bacterial species richness or diversity in non-EBF vs.
EBF 28 and/or trends of increased bacterial diversity across EBF, non-EBF and non-BF.
29,31,32
However, studies report different indices, analyze data in different ways and some do not account for age of infants at the time of stool sample collection, which is associated with breastfeeding status and infant gut microbiota. Our results showed a significant and consistent increase in all four commonly-used alpha diversity indices in non-EBF vs. EBF infants ≤ 6 months of age after adjusting for age of infants at sample collection. We also showed a consistent increase in gut microbiota age in non-EBF infants vs. EBF infants before 6 months of age across studies. At first glance these results may seem paradoxical but we hypothesize that the 13! ! increase in diversity and microbiota age associated with non-EBF in the first 6 months may be out of step with age-appropriate development. A more stable, less diverse gut microbiota, associated with EBF, may be necessary in the early months of development.
There was substantial heterogeneity across studies and populations in gut bacterial taxonomic composition and gut bacterial metabolic pathway composition differences between non-EBF vs.
EBF infants in the first 6 months of life. For example, the decrease in relative abundance of Proteobacteria in non-EBF vs. EBF infants was observed in four studies in North America but the opposite was observed in other studies in Bangladesh, Haiti and South Africa. This heterogeneity may be due to dietary differences or differences in formula ingredients in the non-EBF group across different populations. In addition, the gut microbiota of EBF infants, which is largely seeded by their mothers' breastmilk microbiota and HMOs 3,5,9,12 , might also be influenced by the mother's diet or other exposures, which might also be different across populations 10 . Infant ethnicity has been reported to influence the infant gut microbiota 36 . In addition, variation in the region of 16S RNA gene targeted between studies may also contribute to heterogeneity. Despite this expected variation, our results revealed some important consistencies across populations. Our results showed a consistent increase in the relative abundance of Bacteroidetes in non-EBF vs. EBF infants in all seven studies as well as an overall significant increase in relative abundance of Firmicutes. More specifically, our results showed a persistent increase in relative abundances of genera Bacteroides, Eubacterium and Veillonella in non-EBF vs. EBF infants. While Bifidobacterium is the most common bacterial genus in gastrointestinal tract of young infants, Bacteroides and Eubacterium are the most common bacterial genera in the gastrointestinal tract of adults 37, 38 . Though these genera may be part of
14!
! normal gut bacterial community, the increase in abundance of gut Bacteroides has been shown to be associated with higher body mass index (BMI) in young children 39 and Veillonella can be associated with different types of infection 40 . Our results also showed a consistent increase in relative abundances of major microbial predicted pathways related to carbohydrate metabolism as well as a consistent decrease in relative abundances of crucial pathways related to lipid metabolism/homeostasis, free radical detoxification and metabolism of cofactors and vitamins in non-EBF infants 41 . These findings may provide insight into biological mechanisms for the higher risk of obesity, diabetes and other adverse health outcomes in children who were not breastfed or non-exclusively breastfed in early months of life [25] [26] [27] .
Interestingly, our results revealed notable heterogeneity regarding the perturbation in microbialpredicted functional pathways associated with non-EBF stratified by mode of delivery. The remarkably larger number of perturbed pathways of different cellular and metabolic processes in infants of cesarean deliveries may suggest that gut microbiota in these infants are more vulnerable to the effects of non-EBF. We also observed that non-EBF infants had a much lower abundance of Proteobacterial species than EBF infants after cesarean delivery. It appears that when gut microbiota are depleted with Bacteroidetes, as characteristically in early infancy after cesarean delivery, formula-feeding further depletes Proteobacteria 42 . These findings may shed light on the mechanisms for the higher risk of adverse health outcomes in infants delivered by cesarean section [43] [44] [45] and emphasize the importance of EBF in cesarean-delivered infants.
Differences in breastfeeding practices by mode of delivery may also account for these findings
15!
! Effects of EBF in the first 6 months of life were still evident on the infant gut microbiota between 6 months to 2 years of age. Shorter duration of EBF was associated with increased gut microbiota age as well as earlier and larger increases in relative abundances of many bacterial families other than the beneficial family Bifidobacteriaceae. In contrast, longer EBF maintained a more stable bacterial composition in the early months of life and was associated with higher relative abundance of Bifidobacteriaceae. These findings again support our hypothesis that early changes in gut microbiota associated with non-EBF may be disproportional to immunological and biological maturity of infants in early months. That is, EBF nourishes a stable gut bacterial taxa composition that may be beneficial for the infants who are still immature in early month of life. Our results are also consistent with published literature that exposures in early life can affect the establishment of the gut microbiota in older children and adults 36,47-49 and may help explain the mechanism for the short and long-term health effects of EBF in early months of life.
Another particularly intriguing finding from our analysis is the protective effect of EBF on the infant gut microbiota during diarrheal episodes. Diarrhea has been previously shown to cause perturbations in the gut microbiota 35, 50 . Our analysis revealed that diarrhea was associated with a loss of microbial diversity, microbiota age and the relative abundance of Bifidobacteriaceae as well as an increase in the relative abundance of Streptococcaceae. Incredibly, these changes were almost completely abolished in infants who received more than 2 months of EBF as well as in those who were being breastfed at the time of diarrhea. These findings highlight the importance of longer duration of EBF in the first 6 months of life and continuation of breastfeeding after 6 months of life in maintaining a homeostatic gut microbiota that may be more resistant to outgrowth of pathogenic microbes that lead to diarrhea. Taken together, our findings suggest a 16! ! key role for gut commensal bacteria in mediating the protective effects of breastfeeding on diarrhea morbidity and mortality.
In terms of methodology, our study applied appropriate and robust methodological approaches for the analysis of microbiome data and meta-analysis across microbiome studies.
Standardization of alpha diversity indices and predicted microbiota age from each study makes the estimates of these measures comparable between studies. Zero-inflated beta GAMLSS models allow proper examination of relative abundances of bacterial taxa and predicted functional pathways, which range from zero to one and are generally zero-inflated as well as adjustment for confounding covariates and handling longitudinal or cross-sectional data. The estimates from zero-inflated beta GAMLSS models are log(odds ratio) of relative abundances and thus are comparable between studies. All effect estimates in our analyses were adjusted for variation in age of the infant at sample collection which might largely influence the infant gut microbiota composition as well as breastfeeding status but was not routinely accounted for in analysis 3, 29 or was partially accounted by study design (collecting samples at similar infant age) 31, 33 in some published studies. There have been some published meta-analyses for microbiome data 51-56 but none of these addressed between-group-comparison pooled effects when combining data from many studies as done here. The use of random effect meta-analysis models pooling estimates from studies allows examination of study-specific effects, the heterogeneity between studies, and the overall pooled effects across studies. infants, of which half were born to HIV-infected mothers, which has been shown to influence the infant gut microbiota 3 . The North Carolina study included a very small number of samples in infants ≤ 6 months old (n=21). The VDAART trial (CA-MA-MO) study included samples from infants who were at high risk for asthma and allergies half of whom were randomized to vitamin D supplementation in pregnancy. However, sensitivity meta-analyses excluding these studies showed similar findings to the overall meta-analysis, suggesting that our results are robust.
Finally, all of the results pertaining to samples collected after 6 months of age were from a single study (Bangladesh) and thus should be replicated in other cohorts. However, this study included nearly 1,000 samples collected monthly from birth to 2 years of life in 50 subjects with detailed meta-data 35 .
Conclusion
Our meta-analysis revealed robust findings across populations that may help elucidate the effects of EBF on the infant gut microbiota. Non-EBF or shorter duration of EBF in the first six months 
Methods
Data sources and study population
Processed and partially processed 16S rRNA gene sequence data of stool samples were obtained from seven previously published studies 3, 5, 18, 28, 29, 31, 35 . Of the included studies, three were from the US, one from Canada, one from Haiti, one from South Africa and one from Bangladesh.
There were five studies with three breastfeeding categories (EBF, non-EBF and non-BF) and two studies with two breastfeeding categories (EBF and non-EBF). The total number of samples of infants ≤ 6 months of age included in the overall meta-analyses was 1151 (EBF=547, non-EBF=436, non-BF=168). There were four studies with available information regarding the infants' mode of delivery included in meta-analyses stratified by mode of delivery with a total number of samples of 670 (vaginal deliveries =484, cesarean deliveries =186). The Bangladesh
19!
! study contained 674 samples from 6 months to 2 years of age. In total, 1825 samples of 684 infants were used in our analyses. A summary of the included studies, data characteristics and prior data processing are presented in Table 1 .
Data processing
Sequence data from each included study were processed separately. To achieve necessary data consistency for meta-analyses in this study, OTU picking was performed at 97% similarity using QIIME version 1.9.1 57 with the Greengenes database (version 13.8) 58 . Alpha rarefaction was done in QIIME using default options. Rarefaction depth was selected as the highest depth that retained all study samples. Taxonomic relative abundances from phylum to genus levels and alpha diversity indices were calculated based on rarefied OTU tables. Metagenomic functional compositions of stool bacterial communities were predicted based on the normalized OTU tables using PICRUSt 59 and relative abundances were then calculated for the resulting KEGG (Kyoto Encyclopedia of Genes and Genomes) functional pathways 41 .
Statistical analysis
For each study, mean alpha diversity indices were calculated for each sample at the selected rarefaction depth. Random Forest (RF) modeling of gut microbiota maturity has been widely used to characterize development of the microbiota over chronological time 5, 35, 49 . Adapting the approach from Subramanian et al. 35 , relative abundances of 36 bacterial genera (Supplementary   table 1 ) that were detected in the data of all seven included studies were regressed against infant chronological age using a RF model on the training dataset of the Bangladesh study. The RF model fit based on relative abundances of these shared bacterial genera was then used to predict 20! ! infant age on the test data of the Bangladesh study and the data of each other included study. The predicted infant age based on relative abundances of these shared bacterial genera in each study is referred to as gut microbiota age in this paper. Alpha diversity indices and microbiota age from each study were standardized to have a mean of 0 and standard deviation of 1 to make these measures comparable across studies. Generalized additive mixed model (GAMM) as well as linear mixed effect model with subject random intercept (for longitudinal data) or linear model (for non-longitudinal data) adjusted for infant age at the time of stool sample collection were used to further examine the curves of standardized alpha diversity indices and standardized gut microbiota age over age of infants as well as the difference between groups in each study.
For each study, the summary tables of bacterial taxa and pathway relative abundances were filtered to retain only the taxa and pathways that had an average relative abundance of at least 0.005% and were detected in at least 5% of the number of samples in that study. Relative abundances of bacterial taxa and bacterial KEGG metabolic pathways were examined using Generalized Additive Models for Location Scale and Shape (GAMLSS) with zero inflated beta family (BEZI) and (mu) logit links and other default options as implemented in the R package gamlss 60 . This approach allows proper examination of microbiome relative abundance data, which range from zero to one and are generally zero-inflated, as well as adjustment for covariates (e.g. infant age at sample collection) and handling of longitudinal data by including a subject random effect. In each study, to roughly test for trends across three breastfeeding categories (EBF, non-EBF and non-BF), breastfeeding was coded as a continuous variable in the models.
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To examine overall effects while addressing heterogeneity across studies, random effect metaanalysis models with inverse variance weighting and DerSimonian-Laird estimator for betweenstudy variance were used to pool the adjusted estimates and their standard errors from all included studies. Meta-analyses were done for only bacterial taxa and pathways whose adjusted estimates and standard errors were available in at least 50% of the number of included studies.
All statistical tests were two sided. P-values <0.05 were regarded as significant and false discovery rate (FDR) adjusted p-values <0.1 were regarded as significant after adjusting for multiple testing.
Code availability
The R code used to generate the results in this paper are available at https://github.com/nhanhocu/metamicrobiome_breastfeeding.
Data availability
All data used in the analyses of this study are included in these published articles and their supplementary information files (references 3, 5, 18, 28, 29, 31, 35 confidence intervals (95% CI) were from Generalized Additive Mixed models (GAMM).
b:
The difference in gut microbial alpha diversity (standardized Shannon index) between nonexclusively breastfed (non-EBF) vs. exclusively breastfed (EBF) infants ≤ 6 months of age from each study and the pooled effect across seven included studies (meta-analysis).
c: The trend effect of gut microbial alpha diversity (standardized Shannon index) across EBF, non-EBF and non-BF infants ≤ 6 months of age from each study and the pooled effect across five included studies (meta-analysis). Data from the Haiti and South Africa studies were not 31! ! included as there was no non-BF group in these two studies. In each study, to roughly test for trends across breastfeeding categories, breastfeeding was coded as a continuous variable in the models (EBF=1, non-EBF=2 and non-BF=3).
d: Pooled estimates and 95% CI for the difference in gut microbial alpha diversity (four common alpha diversity indexes (all standardized)) between non-EBF vs. EBF infants ≤ 6 months of age across seven studies.
e: Pooled estimates and 95% CI for the trend effect of gut microbial alpha diversity (four common alpha diversity indexes (all standardized)) across EBF, non-EBF and non-BF infants ≤ 6 months of age.
Estimates for diversity difference or trend and corresponding standard errors from each study were from linear mixed effect models (for longitudinal data) or linear models (for nonlongitudinal data) and were adjusted for age of infants at sample collection. Pooled estimates of a: Gut (standardized) microbiota age of infants ≤ 6 months of age by breastfeeding status by age of infants at stool sample collection from each of seven included studies. Fitted lines and 95%
confidence intervals (95% CI) were from Generalized Additive Mixed models (GAMM).
The difference in gut (standardized) microbiota age between non-exclusively breastfed (non-EBF) vs. EBF infants ≤ 6 months of age from each study and the pooled effect across seven included studies (meta-analysis).
c: The trend of gut (standardized) microbiota age across EBF, non-EBF and non-BF infants ≤ 6 months of age from each study and the pooled effect across five included studies (meta-analysis).
The Haiti and South Africa studies were not included as there was no non-BF group in these two studies. In each study, to test for trend across breastfeeding categories, breastfeeding was coded as a continuous variable in the model (EBF=1, non-EBF=2 and non-BF=3).
Estimates for (standardized) microbiota age difference or trend and corresponding standard error from each study were from linear mixed effect models (for longitudinal data) or linear models (for non-longitudinal data) and were adjusted for age of infants at sample collection.
EBF: exclusive breastfeeding; non-EBF: non-exclusive breastfeeding; non-BF: no breastfeeding;
USA: United States of America; CA: California; FL: Florida; MA: Massachusetts; MO: # Studies with three breastfeeding categories (exclusive breastfeeding (EBF), non-exclusive breastfeeding (non-EBF), non-breastfeeding (non-BF)) used for trend tests across three categories.
$ Studies with available birth mode information used for meta-analysis stratified by birth mode. * This study contains data from 6 months to 2 years of age, which was used for the analysis from 6 months to 2 years of age. Data from this study was downloaded from the authors' website:
https://gordonlab.wustl.edu/Subramanian_6_14/Nature_2014_Processed_16S_rRNA_datasets.html. Data from six other studies were obtained directly from the investigators.
